![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 26, 2016 11:13:34 AM
Stock is up Friday and today because of this. He is flat out wrong. Anyone else know why?? Michael you have to do your homework !!
Dear New World Investor:
Last week, I reminded you that Arch Therapeutics (ARTH) is the current recovery trade, and it was just under my buy limit. I said the next driver for the stock would be signing a deal for European distribution, which should net them a milestone payment large enough to fund the FDA approval process.
In a presentation last week, Terry Norchi, the Chief Executive Officer with an MD and an MBA who used to run Putnam's healthcare fund, commenting on their cash position said: "We had about 12 months of runway and you'll hopefully hear more about that in the not-too-distant future."
CEOs, especially CEOs who have run a major healthcare fund and listened to hundreds of company presentations, do not throw out a tidbit like that unless a deal is imminent. Since Arch does not need cash soon, so it isn't a stock offering, this means to me that a European distribution deal is imminent. I immediately raised my buy limit.
GLTA,
Michael Murphy CFA
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM